L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.

L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.

Item
http://www.wikidata.org/entity/Q37954725
7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disordersSalvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson's disease modelsOptimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression.Designing prodrugs for the treatment of Parkinson's disease.Angiopep-conjugated nanoparticles for targeted long-term gene therapy of Parkinson's disease.Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).Effects of L-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat.Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease.DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons.Brain Targeting of 1,9-Pyrazoloanthrone an c-Jun-N-terminal Kinase Inhibitor Using Liposomes for Effective Management of Parkinson's Disease.
P2860

L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.

Item
http://www.wikidata.org/entity/Q37954725
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.
@en
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.
@nl
type
label
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.
@en
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.
@nl
prefLabel
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.
@en
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment
@en
P2093
P304
P31
P356
10.2174/138161211798194495
P433
P478
P50
P577
P5875
P698
P921